FDA Adverse Event Injury Summary report: N

ASKU

MDR report key: 2208167 · Received August 11, 2011

Report

Report Number
2182208-2011-01494
Event Type
Injury
Date Received
August 11, 2011
Date of Event
June 1, 2011
Report Date
June 1, 2011
Manufacturer
MEDTRONIC, INC.
Product Code
LWS
PMA / PMN Number
ASKU
Removal / Correction Number
ASKU
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

HIS INFORMATION IS BASED ENTIRELY ON JOURNAL LITERATURE. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PATIENT INFORMATION IS LIMITED DUE TO CONFIDENTIALITY CONCERNS. WITHOUT A LOT NUMBER OR DEVICE SERIAL NUMBER, THE MANUFACTURING DATE CANNOT BE DETERMINED. SINCE NO DEVICE ID WAS PROVIDED, IT IS UNKNOWN IF THIS EVENT HAS BEEN PREVIOUSLY REPORTED. REFERENCED ARTICLE: "DISSEMINATED MALIGNANCIES MASQUERADING AS CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICES INFECTIONS." EUROPACE. JUNE 1 2011;13(6):821-824.

Description of Event or Problem · 1

A JOURNAL ARTICLE WAS REVIEWED THAT CONTAINED INFORMATION REGARDING THE DEVICE AND LEADS. THE PATIENT PRESENTED WITH SWELLING OF THE ICD GENERATOR POCKET. A DIAGNOSIS OF POCKET INFECTION WAS MADE AND THE PATIENT WAS SCHEDULED FOR DEVICE AND LEAD REPLACEMENT. DURING THE EXTRACTION PROCEDURE, THE POCKET LOOKED FREE FROM INFECTION, BUT TISSUE SAMPLES WERE TAKEN AND SENT TO PATHOLOGY. THERE WAS ALSO NOTED TISSUE OVER THE ICD POCKET. PER THE AUTHOR, THE RESULTS WERE "CONSISTENT WITH STAGE II DIFFUSE LARGE-CELL LYMPHOMA." THE SYSTEM WAS REPLACED AND THE PATIENT WAS REFERRED TO THE ONCOLOGY SERVICE AND BEGAN RECEIVING CHEMOTHERAPY, WITH GOOD RESPONSE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ASKU IMPLANTABLE PACEMAKER/CARDIO/DEFIB LWS MEDTRONIC, INC. ICD/MEDT ASKU

Patients

Seq Age Sex Outcome Treatment
1 60 YR Hospitalization| R